Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 70700-315

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 70700-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logarithmic Scale.jpg (Image 01)

This text provides information on odds ratios with their corresponding 95% confidence intervals for different studies examining the risk associated with Depo-Provera (DMPA) use for at least 12 months. The odds ratios for DMPA use are presented for various studies along with the interpretation that a ratio greater than 1 indicates an increased risk.*

FDA Label Image

Structure (Image 02)

FDA Label Image

Image (Image 03)

This text provides information on the rates of pregnancies per 100 women in one year under different scenarios, as well as various contraceptive methods that can be used to prevent pregnancies. Methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, and strategies like no sex during the most fertile days of the monthly cycle, spermicide, withdrawal are mentioned. Additionally, options for both fewer pregnancies and more pregnancies are discussed.*

FDA Label Image

Carton 1 (Image 04)

FDA Label Image

Carton (Image 05)

FDA Label Image

Vial (Image 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.